Back to Search
JUSTIN MACKEY, M.D.
Diagnostic Radiology Physician
NPI: 1275782849IndividualAccepts Medicare
Specialties, Licenses & Credentials
Body Imaging Physician
Radiology — Body Imaging
Code: 2085B0100X
437260(PA)
Diagnostic Radiology PhysicianPrimary
Radiology — Diagnostic Radiology
Code: 2085R0202X
245913(NY)
Education
NEW YORK MEDICAL COLLEGE
Class of 2004
Research & Publications (20)
Predicting pertussis in a pediatric emergency department population.
PMID 17556741·Clin Pediatr (Phila)·2007
8-other
Quantitative analysis of nucleoside transporter and metabolism gene expression in chronic lymphocytic leukemia (CLL): identification of fludarabine-sensitive and -insensitive populations.
PMID 15454483·Blood·2005
3-trial
Skeletal health in postmenopausal survivors of early breast cancer.
PMID 15645435·Int J Cancer·2005
6-review
High-dose ibuprofen therapy associated with esophageal ulceration after pneumonectomy in a patient with cystic fibrosis: a case report.
PMID 15363106·BMC Pediatr·2004
5-case
Immunohistochemical variation of human equilibrative nucleoside transporter 1 protein in primary breast cancers.
PMID 11801546·Clin Cancer Res·2002
4-observational
Frequency of celiac disease in individuals with Down syndrome in the United States.
PMID 11388673·Clin Pediatr (Phila)·2001
8-other
Effectiveness of remifentanil versus traditional fentanyl-based anesthetic in high-risk outpatient surgery.
PMID 11090727·J Clin Anesth·2000
3-trial
A phase II trial of triamcinolone hexacetanide for symptomatic recurrent malignant ascites.
PMID 10760624·J Pain Symptom Manage·2000
3-trial
Predictors of distress and quality of life in patients undergoing cancer therapy: impact of treatment type and decisional role.
PMID 19557823·Psychooncology·2010
8-other
Exercise intolerance in cancer and the role of exercise therapy to reverse dysfunction.
PMID 19482248·Lancet Oncol·2009
6-review
Human equilibrative nucleoside transporter 1 levels predict response to gemcitabine in patients with pancreatic cancer.
PMID 18992248·Gastroenterology·2009
3-trial
Sarcopenia as a determinant of chemotherapy toxicity and time to tumor progression in metastatic breast cancer patients receiving capecitabine treatment.
PMID 19351764·Clin Cancer Res·2009
8-other
Species-specific activity of SIV Nef and HIV-1 Vpu in overcoming restriction by tetherin/BST2.
PMID 19436700·PLoS Pathog·2009
7-preclinical
Predictors of follow-up exercise behavior 6 months after a randomized trial of exercise training during breast cancer chemotherapy.
PMID 18389368·Breast Cancer Res Treat·2009
2-rct
Prospective cohort study of lifetime physical activity and breast cancer survival.
PMID 19123472·Int J Cancer·2009
8-other
Breast cancer subtypes and response to docetaxel in node-positive breast cancer: use of an immunohistochemical definition in the BCIRG 001 trial.
PMID 19204205·J Clin Oncol·2009
8-other
Human equilibrative nucleoside transporter 1 and human concentrative nucleoside transporter 3 predict survival after adjuvant gemcitabine therapy in resected pancreatic adenocarcinoma.
PMID 19318496·Clin Cancer Res·2009
8-other
Impact of clinical practice guidelines on the management for carcinomas of unknown primary site: a controlled "before-after" study.
PMID 19435692·Bull Cancer·2009
4-observational
Adjuvant trastuzumab induces ventricular remodeling despite aerobic exercise training.
PMID 19622583·Clin Cancer Res·2009
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1500 LANSDOWNE AVE
DARBY, PA 19023 - Phone
- (914) 584-6245
Quick Facts
- NPI
- 1275782849
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile